OPPENHEIMER ASSET MANAGEMENT INC. - ARROWHEAD PHARMACEUTICALS IN ownership

Back to all holdings Add to watchlist

ARROWHEAD PHARMACEUTICALS IN's ticker is ARWR and the CUSIP is 04280A100. A total of 267 filers reported holding ARROWHEAD PHARMACEUTICALS IN in Q3 2020. The put-call ratio across all filers is 0.63 and the average weighting 0.2%.

Links
Filings
External links
Quarter-by-quarter ownership
OPPENHEIMER ASSET MANAGEMENT INC. ownership history of ARROWHEAD PHARMACEUTICALS IN
ValueSharesWeighting
Q4 2022$510,732
+10.5%
12,592
-9.8%
0.01%0.0%
Q3 2022$462,000
-9.2%
13,964
-3.4%
0.01%
-11.1%
Q2 2022$509,000
-25.5%
14,449
-2.7%
0.01%
-10.0%
Q1 2022$683,000
-31.1%
14,845
-0.8%
0.01%
-23.1%
Q4 2021$992,000
+2.1%
14,960
-3.9%
0.01%
-7.1%
Q3 2021$972,000
-27.8%
15,563
-4.3%
0.01%
-26.3%
Q2 2021$1,346,000
+22.6%
16,256
-1.9%
0.02%
+11.8%
Q1 2021$1,098,000
-16.1%
16,564
-2.8%
0.02%
-22.7%
Q4 2020$1,308,000
+74.9%
17,048
-1.8%
0.02%
+46.7%
Q3 2020$748,000
-0.9%
17,362
-0.6%
0.02%
-6.2%
Q2 2020$755,000
+52.2%
17,471
+1.2%
0.02%
+33.3%
Q1 2020$496,000
-55.6%
17,256
-1.9%
0.01%
-50.0%
Q4 2019$1,116,000
+120.1%
17,599
-2.1%
0.02%
+118.2%
Q3 2019$507,000
+4.3%
17,981
-1.9%
0.01%0.0%
Q2 2019$486,000
+23.0%
18,323
-14.7%
0.01%
+22.2%
Q1 2019$395,000
+18.3%
21,481
-20.1%
0.01%
+12.5%
Q4 2018$334,000–26,872–0.01%–
 Download
Other shareholders
ARROWHEAD PHARMACEUTICALS IN shareholders Q3 2020
NameSharesValueWeighting ↓
Aquilo Capital Management, LLC 908,474$24,410,69622.12%
Western Financial Corp/CA 820,239$22,039,82216.16%
JOHNSON & JOHNSON 247,598$6,652,9582.45%
WEALTH EFFECTS LLC 164,750$4,426,8352.19%
M28 Capital Management LP 67,400$1,811,0382.08%
Privium Fund Management B.V. 259,036$6,960,2982.07%
Evolutionary Tree Capital Management, LLC 51,266$1,377,5171.78%
Avidity Partners Management LP 1,063,897$28,586,9121.15%
SECTORAL ASSET MANAGEMENT INC 157,552$4,233,4220.82%
Vivo Capital, LLC 137,411$3,692,2340.40%
View complete list of ARROWHEAD PHARMACEUTICALS IN shareholders